Pfizer forecasts $54 billion in revenue in 2022 from sales of its Covid vaccine and antiviral pill - Daily Mail

Pfizer estimates that it will rake in record-breaking earnings of more than $100 billion this year due to sales of its COVID-19 vaccine and antiviral pill to treat the virus.     The rollout of the … [+4871 chars]